Blog

Shares of TG Therapeutics TGTX have risen 29% in the past three months, driven by the robust sales performance of its sole marketed drug, Briumvi (ublituximab-xiiy). The company’s top line primarily

Ernexa Therapeutics’ ERNA shares rallied 140.2% in a month, primarily driven by encouraging preclinical results for its lead cell therapy candidate, ERNA-101, in ovarian cancer. The sharp stock move

Wednesday, May 20th, 2026Pre-market futures are up this morning, filling in some holes from Tuesday’s session that closed in the red. Major indexes are fighting back to all-time-high levels (on the

Pfizer PFE is one of the world’s leading oncology drugmakers, with a strong presence across breast, genitourinary, thoracic, gastrointestinal and hematologic cancers. The company has built a broad

Halliburton HAL, a Houston, TX-based oil and gas equipment and services company, has unveiled its latest innovation in subsurface reservoir evaluation, the Xaminer Deep Testing logging service, an

Petrobras PBR has confirmed a significant discovery of hydrocarbons in the pre-salt Santos Basin with the appraisal well 3-BRSA-1387D-SPS in the Aram Block, according to Offshore Magazine. Located

Target Corporation TGT reported first-quarter fiscal 2026 results, wherein both top and bottom lines surpassed the Zacks Consensus Estimate and improved year over year. The company witnessed

OptimizeRx Corporation OPRX stock has lost 30.4% in the past month compared with the Zacks Computer Software industry’s decline of 0.8%. The stock has also underperformed the Zacks Computer &

Block’s XYZ Square is strengthening its presence in the restaurant and mid-market segments through point-of-sale and commerce solutions that help sellers accept payments, manage operations and

UiPath PATH continues to demonstrate steady recurring revenue expansion, reinforcing the company’s long-term positioning within enterprise automation and AI-driven workflow orchestration.

PATH has

Cenovus Energy Inc. CVE has a diversified portfolio with assets spanning both upstream exploration and downstream refining. The company generates substantial revenues from its upstream operations

Exxon Mobil Corporation XOM maintains a diversified global portfolio with a strategic presence in upstream and downstream operations. The majority of revenues are generated from its advantaged

Comfort Systems USA, Inc. FIX entered 2026 with extraordinary momentum, but investors are now asking whether its record-breaking backlog can continue fueling its rapid expansion. After posting

Sterling Infrastructure, Inc. STRL is rapidly transforming from a traditional site-development contractor into a full-scale mission-critical infrastructure partner, and its cross-selling strategy

Keysight Technologies, Inc. KEYS reported mixed second-quarter fiscal 2026 results, with the bottom line beating the Zacks Consensus Estimate while the top line missing the same. The leading

Palantir Technologies PLTR continues to demonstrate strong momentum in customer acquisition, highlighting growing enterprise demand for its artificial intelligence and data analytics platforms

PVH Corporation PVH benefits from strength in its core brands, such as Calvin Klein and Tommy Hilfiger, which continue to leverage solid global recognition and strong pricing power across markets

Kratos Defense & Security Solutions, Inc. KTOS continues strengthening its revenue visibility through a growing backlog tied to defense, satellite communications and unmanned systems programs. As of

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 20:

Lumentum Holdings Inc. LITE: This photonics company has a Zacks Rank #1 and witnessed

Equifax’s EFX sustained revenue growth momentum is driven by its diverse offerings. New acquisitions and AI innovations in analytical tools and solutions boost customer gains.

EFX has a Growth Score

The market expects Bath & Body Works (BBWI) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2026. This widely-known consensus

The market expects Dick's Sporting Goods (DKS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known

The market expects Salesforce (CRM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus outlook

The market expects Abercrombie & Fitch (ANF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus